ERTOLD pathway

The ERTOLD pathway is one of two pathways (ie., the ERTOLD & CYTOLD pathways) which are known to mediate protein localization to the surface of lipid droplets. Unlike proteins targeting other cellular organelles, lipid droplet proteins have no distinct targeting signal or localization sequence embedded within their amino acid sequence.[1] Nevertheless, the surface of the lipid droplet is decorated with a vast and diverse repertoire of proteins, the number of which varies from species to species.[1]

The mechanisms by which this large and highly dynamic set of proteins traffic to the lipid droplet (LD) surface have been classified into two main categories (class I and class II), by virtue of their pathway for targeting the LD surface: the CYTOLD pathway, which mediates protein targeting from the cytosol to LDs, and the ERTOLD pathway, which directs protein targeting from the endoplasmic reticulum to LDs.[1][2]

Mechanisms of protein trafficking to the lipid droplet (LD) surface have been an area of intense modern research. Protein association with the lipid droplet surface (which is a phospholipid monolayer) occurs via hydrophobic hairpins, lipidated domains, and amphipathic helices, or by binding to another protein on the LD surface.[1] The first and best-characterized family of lipid droplet associated proteins is the perilipin protein family, consisting of five proteins. These include perilipin 1 (PLIN1), perilipin 2 (PLIN2), perilipin 3 (PLIN3), perilipin 4 (PLIN4) and perilipin 5 (PLIN5). Proteomics studies have elucidated the association of many other families of proteins to the lipid surface, including those involved in membrane trafficking, vesicle docking, endocytosis and exocytosis.[1]

Class I proteins: ERTOLD pathway

Class I proteins enter the lipid droplet (LD) surface by virtue of the ERTOLD pathway, where they are first inserted into the ER membrane and are thereafter trafficked onto the LD surface. Class I proteins form characteristic stable membrane association with the phospholipid monolayer of the LD, with this most commonly achieved via insertion of hydrophobic hairpin segments into the membrane and core.[1] Within this configuration, class I proteins retain cytosolic exposure of both the C-terminus and N-terminus, thus creating ample opportunity for other cytosolic proteins to act upon the LD in cell signaling cascades.[1] Class I proteins explicitly lack luminal domains, as these would preclude their movement within the ER bilayer and onto the LD surface.[1][3] As such, polytopic membrane proteins can never be class I proteins, nor will they enter the LD surface via the ERTOLD pathway.[1][3]

Although the structural features of class I proteins allow for their free movement between the ER bilayer and the LD surface, it remains unclear how the relative partitioning between the two organelles is controlled.[1] Targeting to LDs is favored when the hairpin structure of class I proteins is flanked by positively charged residues, which may facilitate more energetically stable conformations on the LD surface compared to the ER bilayer.[3][4][5] Certain class I proteins display an affinity for triacylglycerol (TAG) about their hairpin loop, which drives their concentration at the LD surface.[1][6] Conversely, some class I proteins may be actively retained on the ER surface through protein-protein interactions.[1] For example, UBXD8 is selectively partitioned onto the ER bilayer when bound to UBAC2, a polytopic ER membrane protein.[1][7][8] Selective degradation of certain hairpin-containing proteins in the ER results in their effective accumulation at the LD surface.[1][9][10][11] Although these examples and putative mechanisms offer insights as to the regulation of class I protein partitioning between the ER and LD surface, a complete mechanistic understanding of this process has yet to be uncovered.[1]

Several imaging studies have revealed that some class I proteins localize to LDs during the earliest stages of LD biogenesis, while other proteins target LDs much later.[1][3][12] Such observations suggest the existence of at least two ERTOLD pathways that effectively stage LD protein targeting in an orderly fashion.[1] Interestingly, recent research reports seem to further evidence the existence of such "early" and "late" ERTOLD pathways.[1] Recently, some class I proteins have been shown to target LDs during the budding phase of early LD biogenesis, where they appeared to diffuse onto LDs from the ER through the Seipin-stabilized neck.[1][13] By contrast, other class I proteins were shown to be initially rejected at the Seipin gate and appeared to follow another distinct route, which depends on machinery typically associated with anterograde vesicular traffic in the early secretory pathway.[1][13]

Factors relevant to this latent ERTOLD pathway include components of the COPII coat complex (Sec23 and Sec24), ER exit site factors (Sec12, Sec16, Sar1, and Tango1), membrane tethering complexes (TRAPP and COG complex subunits), and Rab proteins as well as SNARE proteins known for their importance in membrane fusion.[1] These findings led to the idea that the late ERTOLD targeting pathway may involve the establishment of distinct membrane bridges between the ER and LD, which may function in a Seipin-independent fashion.[1] In the absence of Seipin, late ERTOLD pathway cargo appears much earlier upon the LD surface,[13] further supporting earlier studies in yeast and mammalian cells, which showed the central role of Seipin was not only concentrating triacyl glycerol (TAG), but also regulating the LD proteome by gating movement of class I proteins between the ER and LD surface.[1][14][15]

Class II proteins: CYTOLD pathway

Class II proteins enter the LD surface by virtue of the CYTOLD pathway, where they are recruited directly from the cytosol to the phospholipid monolayer, supported in some cases by chaperone proteins.[1] Class II proteins associate with LDs via a variety of mechanisms, including direct binding onto other LD proteins or association with the lipid monolayer using a lipid anchor.[1][16] Most frequently, class II proteins are found bound to LDs via amphipathic alpha-helices (AHs), in which hydrophobic and polar residuespartition to opposite sides of the helix.[1][17][18][19][20][21]

Interestingly, the specificity of AH-containing proteins for the LD monolayer appears to be caused by phospholipid packing defects and the higher surface tension of the LD monolayer relative to the phospholipid bilayer of all other cellular organelles.[1][20] This specificity is further increased in AH-containing proteins whose AHs are known to interact directly with TAG.[19][22] However, not all AH-containing LD proteins behave as class II proteins.[1] Recently, it was shown that some class I protein trafficking to the LD monolayer is also mediated by AHs.[1][23] Comparison of multiple AHs suggests that class I behavior is favored for AHs with a reduced number of charged residues along the polar face, possibly due to the greater allowance for extensive interactions with the phospholipid side chains.[1][23] Conversely, class II behavior is favored for AHs with a greater presence of charged residues, as such reduces the axial hydrophobic surface of the AH.[23]

References

  1. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad Klemm, Robin W.; Carvalho, Pedro (2024-10-02). "Lipid Droplets Big and Small: Basic Mechanisms That Make Them All". Annual Review of Cell and Developmental Biology. 40: 143–168. doi:10.1146/annurev-cellbio-012624-031419. ISSN 1081-0706. PMID 39356808.
  2. ^ Olarte, Maria-Jesus; Swanson, Jessica M. J.; Walther, Tobias C.; Farese, Robert V. (January 2022). "The CYTOLD and ERTOLD pathways for lipid droplet-protein targeting". Trends in Biochemical Sciences. 47 (1): 39–51. doi:10.1016/j.tibs.2021.08.007. ISSN 0968-0004. PMC 8688270. PMID 34583871.
  3. ^ a b c d Wilfling, Florian; Wang, Huajin; Haas, Joel T.; Krahmer, Natalie; Gould, Travis J.; Uchida, Aki; Cheng, Ji-Xin; Graham, Morven; Christiano, Romain; Fröhlich, Florian; Liu, Xinran; Buhman, Kimberly K.; Coleman, Rosalind A.; Bewersdorf, Joerg; Farese, Robert V. (2013-02-25). "Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets". Developmental Cell. 24 (4): 384–399. Bibcode:2013DevCe..24..384W. doi:10.1016/j.devcel.2013.01.013. ISSN 1878-1551. PMC 3727400. PMID 23415954.
  4. ^ Ingelmo-Torres, Mercedes; González-Moreno, Elena; Kassan, Adam; Hanzal-Bayer, Michael; Tebar, Francesc; Herms, Albert; Grewal, Thomas; Hancock, John F.; Enrich, Carlos; Bosch, Marta; Gross, Steven P.; Parton, Robert G.; Pol, Albert (December 2009). "Hydrophobic and basic domains target proteins to lipid droplets". Traffic (Copenhagen, Denmark). 10 (12): 1785–1801. doi:10.1111/j.1600-0854.2009.00994.x. ISSN 1600-0854. PMC 2913680. PMID 19874557.
  5. ^ Olarte, Maria-Jesus; Kim, Siyoung; Sharp, Morris E.; Swanson, Jessica M. J.; Farese, Robert V.; Walther, Tobias C. (2020-08-24). "Determinants of Endoplasmic Reticulum-to-Lipid Droplet Protein Targeting". Developmental Cell. 54 (4): 471–487.e7. doi:10.1016/j.devcel.2020.07.001. ISSN 1878-1551. PMC 7696655. PMID 32730754.
  6. ^ Caillon, Lucie; Nieto, Vincent; Gehan, Pauline; Omrane, Mohyeddine; Rodriguez, Nicolas; Monticelli, Luca; Thiam, Abdou Rachid (2020-08-07). "Triacylglycerols sequester monotopic membrane proteins to lipid droplets". Nature Communications. 11 (1): 3944. Bibcode:2020NatCo..11.3944C. doi:10.1038/s41467-020-17585-8. ISSN 2041-1723. PMC 7414839. PMID 32769983.
  7. ^ Olzmann, James A.; Richter, Caleb M.; Kopito, Ron R. (2013-01-22). "Spatial regulation of UBXD8 and p97/VCP controls ATGL-mediated lipid droplet turnover". Proceedings of the National Academy of Sciences of the United States of America. 110 (4): 1345–1350. Bibcode:2013PNAS..110.1345O. doi:10.1073/pnas.1213738110. ISSN 1091-6490. PMC 3557085. PMID 23297223.
  8. ^ Schrul, Bianca; Kopito, Ron R. (July 2016). "Peroxin-dependent targeting of a lipid-droplet-destined membrane protein to ER subdomains". Nature Cell Biology. 18 (7): 740–751. doi:10.1038/ncb3373. ISSN 1476-4679. PMC 4925261. PMID 27295553.
  9. ^ Bersuker, Kirill; Peterson, Clark W. H.; To, Milton; Sahl, Steffen J.; Savikhin, Victoria; Grossman, Elizabeth A.; Nomura, Daniel K.; Olzmann, James A. (2018-01-08). "A Proximity Labeling Strategy Provides Insights into the Composition and Dynamics of Lipid Droplet Proteomes". Developmental Cell. 44 (1): 97–112.e7. doi:10.1016/j.devcel.2017.11.020. ISSN 1878-1551. PMC 5764092. PMID 29275994.
  10. ^ Roberts, Melissa A.; Deol, Kirandeep K.; Mathiowetz, Alyssa J.; Lange, Mike; Leto, Dara E.; Stevenson, Julian; Hashemi, Sayed Hadi; Morgens, David W.; Easter, Emilee; Heydari, Kartoosh; Nalls, Mike A.; Bassik, Michael C.; Kampmann, Martin; Kopito, Ron R.; Faghri, Faraz (2023-09-25). "Parallel CRISPR-Cas9 screens identify mechanisms of PLIN2 and lipid droplet regulation". Developmental Cell. 58 (18): 1782–1800.e10. doi:10.1016/j.devcel.2023.07.001. ISSN 1878-1551. PMC 10530302. PMID 37494933.
  11. ^ Ruggiano, A.; Mora, G.; Buxó, L.; Carvalho, P. (2016). "Spatial control of lipid droplet proteins by the ERAD ubiquitin ligase Doa10". EMBO Journal. 35 (15): 1644–1655. doi:10.15252/embj.201593106. ISSN 0261-4189. PMC 4969576. PMID 27357570.
  12. ^ Jacquier, Nicolas; Choudhary, Vineet; Mari, Muriel; Toulmay, Alexandre; Reggiori, Fulvio; Schneiter, Roger (2011-07-15). "Lipid droplets are functionally connected to the endoplasmic reticulum in Saccharomyces cerevisiae". Journal of Cell Science. 124 (Pt 14): 2424–2437. doi:10.1242/jcs.076836. ISSN 1477-9137. PMID 21693588.
  13. ^ a b c Song, Jiunn; Mizrak, Arda; Lee, Chia-Wei; Cicconet, Marcelo; Lai, Zon Weng; Tang, Wei-Chun; Lu, Chieh-Han; Mohr, Stephanie E.; Farese, Robert V.; Walther, Tobias C. (September 2022). "Identification of two pathways mediating protein targeting from ER to lipid droplets". Nature Cell Biology. 24 (9): 1364–1377. doi:10.1038/s41556-022-00974-0. ISSN 1476-4679. PMC 9481466. PMID 36050470.
  14. ^ Grippa, Alexandra; Buxó, Laura; Mora, Gabriel; Funaya, Charlotta; Idrissi, Fatima-Zahra; Mancuso, Francesco; Gomez, Raul; Muntanyà, Júlia; Sabidó, Eduard; Carvalho, Pedro (2015-11-23). "The seipin complex Fld1/Ldb16 stabilizes ER-lipid droplet contact sites". The Journal of Cell Biology. 211 (4): 829–844. doi:10.1083/jcb.201502070. ISSN 1540-8140. PMC 4657162. PMID 26572621.
  15. ^ Salo, Veijo T.; Belevich, Ilya; Li, Shiqian; Karhinen, Leena; Vihinen, Helena; Vigouroux, Corinne; Magré, Jocelyne; Thiele, Christoph; Hölttä-Vuori, Maarit; Jokitalo, Eija; Ikonen, Elina (2016-12-15). "Seipin regulates ER-lipid droplet contacts and cargo delivery". The EMBO Journal. 35 (24): 2699–2716. doi:10.15252/embj.201695170. ISSN 1460-2075. PMC 5167346. PMID 27879284.
  16. ^ Olarte, Maria-Jesus; Swanson, Jessica M. J.; Walther, Tobias C.; Farese, Robert V. (January 2022). "The CYTOLD and ERTOLD pathways for lipid droplet-protein targeting". Trends in Biochemical Sciences. 47 (1): 39–51. doi:10.1016/j.tibs.2021.08.007. ISSN 0968-0004. PMC 8688270. PMID 34583871.
  17. ^ Chorlay, Aymeric; Monticelli, Luca; Veríssimo Ferreira, Joana; Ben M'Barek, Kalthoum; Ajjaji, Dalila; Wang, Sihui; Johnson, Errin E.; Beck, Rainer; Omrane, Mohyeddine; Beller, Mathias; Carvalho, Pedro; Thiam, Abdou Rachid (July 2019). "Membrane Asymmetry Imposes Directionality on Lipid Droplet Emergence from the ER". Developmental Cell. 50 (1): 25–42.e7. doi:10.1016/j.devcel.2019.05.003. PMID 31155466.
  18. ^ Barneda, David; Planas-Iglesias, Joan; Gaspar, Maria L.; Mohammadyani, Dariush; Prasannan, Sunil; Dormann, Dirk; Han, Gil-Soo; Jesch, Stephen A.; Carman, George M.; Kagan, Valerian; Parker, Malcolm G.; Ktistakis, Nicholas T.; Klein-Seetharaman, Judith; Dixon, Ann M.; Henry, Susan A. (2015-11-26). "The brown adipocyte protein CIDEA promotes lipid droplet fusion via a phosphatidic acid-binding amphipathic helix". eLife. 4 e07485. doi:10.7554/eLife.07485. ISSN 2050-084X. PMC 4755750. PMID 26609809.
  19. ^ a b Čopič, Alenka; Antoine-Bally, Sandra; Giménez-Andrés, Manuel; La Torre Garay, César; Antonny, Bruno; Manni, Marco M.; Pagnotta, Sophie; Guihot, Jeanne; Jackson, Catherine L. (2018-04-06). "A giant amphipathic helix from a perilipin that is adapted for coating lipid droplets". Nature Communications. 9 (1): 1332. doi:10.1038/s41467-018-03717-8. ISSN 2041-1723. PMC 5889406. PMID 29626194.
  20. ^ a b Prévost, Coline; Sharp, Morris E.; Kory, Nora; Lin, Qingqing; Voth, Gregory A.; Farese, Robert V.; Walther, Tobias C. (2018-01-08). "Mechanism and Determinants of Amphipathic Helix-Containing Protein Targeting to Lipid Droplets". Developmental Cell. 44 (1): 73–86.e4. doi:10.1016/j.devcel.2017.12.011. ISSN 1878-1551. PMC 5764114. PMID 29316443.
  21. ^ Rowe, Emily R.; Mimmack, Michael L.; Barbosa, Antonio D.; Haider, Afreen; Isaac, Iona; Ouberai, Myriam M.; Thiam, Abdou Rachid; Patel, Satish; Saudek, Vladimir; Siniossoglou, Symeon; Savage, David B. (2016-03-25). "Conserved Amphipathic Helices Mediate Lipid Droplet Targeting of Perilipins 1-3". The Journal of Biological Chemistry. 291 (13): 6664–6678. doi:10.1074/jbc.M115.691048. ISSN 1083-351X. PMC 4807253. PMID 26742848.
  22. ^ Giménez-Andrés, Manuel; Emeršič, Tadej; Antoine-Bally, Sandra; D'Ambrosio, Juan Martin; Antonny, Bruno; Derganc, Jure; Čopič, Alenka (2021-04-15). "Exceptional stability of a perilipin on lipid droplets depends on its polar residues, suggesting multimeric assembly". eLife. 10 e61401. doi:10.7554/eLife.61401. ISSN 2050-084X. PMC 8064757. PMID 33856341.
  23. ^ a b c Pataki, Camille I.; Rodrigues, João; Zhang, Lichao; Qian, Junyang; Efron, Bradley; Hastie, Trevor; Elias, Joshua E.; Levitt, Michael; Kopito, Ron R. (2018-08-28). "Proteomic analysis of monolayer-integrated proteins on lipid droplets identifies amphipathic interfacial α-helical membrane anchors". Proceedings of the National Academy of Sciences of the United States of America. 115 (35): E8172–E8180. Bibcode:2018PNAS..115E8172P. doi:10.1073/pnas.1807981115. ISSN 1091-6490. PMC 6126764. PMID 30104359.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.